Animalcare Group (ANCR) Competitors GBX 294 0.00 (0.00%) As of 07/4/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsHeadlinesBuy This Stock ANCR vs. AMYT, AGY, APH, VLG, DNL, EAH, STX, PXS, CHLL, and MXCShould you be buying Animalcare Group stock or one of its competitors? The main competitors of Animalcare Group include Amryt Pharma (AMYT), Allergy Therapeutics (AGY), Alliance Pharma (APH), Venture Life Group (VLG), Diurnal Group (DNL), ECO Animal Health Group (EAH), Shield Therapeutics (STX), Provexis (PXS), Chill Brands Group (CHLL), and Argent BioPharma (MXC). These companies are all part of the "drug manufacturers - specialty & generic" industry. Animalcare Group vs. Its Competitors Amryt Pharma Allergy Therapeutics Alliance Pharma Venture Life Group Diurnal Group ECO Animal Health Group Shield Therapeutics Provexis Chill Brands Group Argent BioPharma Animalcare Group (LON:ANCR) and Amryt Pharma (LON:AMYT) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, profitability, valuation, earnings, media sentiment and analyst recommendations. Does the media prefer ANCR or AMYT? In the previous week, Animalcare Group's average media sentiment score of 0.00 equaled Amryt Pharma'saverage media sentiment score. Company Overall Sentiment Animalcare Group Neutral Amryt Pharma Neutral Is ANCR or AMYT more profitable? Animalcare Group has a net margin of 43.05% compared to Amryt Pharma's net margin of 0.00%. Animalcare Group's return on equity of 36.62% beat Amryt Pharma's return on equity.Company Net Margins Return on Equity Return on Assets Animalcare Group43.05% 36.62% 2.97% Amryt Pharma N/A N/A N/A Do insiders & institutionals believe in ANCR or AMYT? 49.0% of Animalcare Group shares are owned by institutional investors. 29.5% of Animalcare Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has higher valuation & earnings, ANCR or AMYT? Animalcare Group has higher earnings, but lower revenue than Amryt Pharma. Amryt Pharma is trading at a lower price-to-earnings ratio than Animalcare Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAnimalcare Group£84.90M2.37£36.55M£53.645.48Amryt Pharma£210.24M0.00N/A-£33.00N/A SummaryAnimalcare Group beats Amryt Pharma on 7 of the 8 factors compared between the two stocks. Get Animalcare Group News Delivered to You Automatically Sign up to receive the latest news and ratings for ANCR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ANCR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ANCR vs. The Competition Export to ExcelMetricAnimalcare GroupDrug Manufacturers IndustryMedical SectorLON ExchangeMarket Cap£201.57M£2.13B£5.53B£2.96BDividend Yield2.05%2.92%5.24%5.02%P/E Ratio5.484.1827.63147.88Price / Sales2.37566.59417.36258,917.23Price / Cash26.0510.3536.8927.97Price / Book1.8211.628.034.61Net Income£36.55M£21.15B£3.18B£5.90B7 Day Performance-0.59%1.74%2.91%1.04%1 Month Performance-1.34%5.20%3.72%5.12%1 Year Performance25.53%2.38%35.14%80.82% Animalcare Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ANCRAnimalcare GroupN/AGBX 294flatN/A+27.1%£201.57M£84.90M5.48220Gap DownAMYTAmryt PharmaN/AN/AN/AN/A£457.11M£210.24M-4.33290Gap DownAGYAllergy TherapeuticsN/AGBX 7.45+2.1%N/A+66.7%£366.17M£72.18M-7.18612Gap DownHigh Trading VolumeAPHAlliance Pharma2.1618 of 5 starsGBX 64.70flatGBX 6,250+9,560.0%N/A£350.32M£183.50M-10.4391,000VLGVenture Life GroupN/AGBX 50flatN/A+41.8%£63.71M£51.77M84.85165News CoveragePositive NewsEarnings ReportInsider TradeDNLDiurnal GroupN/AN/AN/AN/A£46.33M£4.68M-3.2133News CoverageEAHECO Animal Health GroupN/AGBX 61.45-0.9%N/A-53.9%£41.64M£89.44M39.72234Gap DownSTXShield TherapeuticsN/AGBX 3.05+7.0%N/A+70.0%£30.10M£20.92M-0.7940,000High Trading VolumePXSProvexisN/AGBX 0.63-3.1%N/A+60.9%£14.78M£846.98K-23.884Positive NewsGap DownCHLLChill Brands GroupN/AN/AN/AN/A£10.89M£624.19K-215.007MXCArgent BioPharmaN/AN/AN/AN/A£9.65M£1.32M-13.255Gap Up Related Companies and Tools Related Companies Amryt Pharma Alternatives Allergy Therapeutics Alternatives Alliance Pharma Alternatives Venture Life Group Alternatives Diurnal Group Alternatives ECO Animal Health Group Alternatives Shield Therapeutics Alternatives Provexis Alternatives Chill Brands Group Alternatives Argent BioPharma Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:ANCR) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Animalcare Group plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Animalcare Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
